Reckitt Benckiser Group (LON:RKT) Shares Up 0.3% - Here's Why

Reckitt Benckiser Group plc (LON:RKT - Get Free Report)'s stock price traded up 0.3% during mid-day trading on Tuesday . The stock traded as high as GBX 5,354 ($67.64) and last traded at GBX 5,338 ($67.44). 1,126,737 shares traded hands during mid-day trading, a decline of 70% from the average session volume of 3,728,999 shares. The stock had previously closed at GBX 5,324 ($67.26).

Reckitt Benckiser Group Price Performance

The company has a debt-to-equity ratio of 110.26, a current ratio of 0.69 and a quick ratio of 0.46. The company has a 50-day moving average price of GBX 5,036.99 and a 200-day moving average price of GBX 4,764.82. The firm has a market capitalization of £36.01 billion, a PE ratio of 24.15, a P/E/G ratio of 1.10 and a beta of 0.09.

Insider Activity

In related news, insider Shannon Eisenhardt sold 1,368 shares of the stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of GBX 4,723 ($59.67), for a total transaction of £64,610.64 ($81,630.63). Company insiders own 0.05% of the company's stock.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.